There has been no news at all of any consequence on the phase 1a cancer trial. Already, we can have a high degree of confidence that the phase 1a will be declared a success and will move onto phase 1b. The only issue right now is whether we will catch a lucky break and there will be some preliminary evidence shown in the phase 1a that the Docetaxel is getting into cancer cells and killing them. So
...more